O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+38.81%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$11.4B
AUM Growth
+$11.4B
(+44%)
Cap. Flow
+$1.3B
Cap. Flow
% of AUM
11.42%
Top 10 Holdings %
Top 10 Hldgs %
37.61%
Holding
165
New
23
Increased
27
Reduced
20
Closed
17
Top Buys
| 1 |
ARS Pharmaceuticals
SPRY
|
$405M |
| 2 |
AbCellera Biologics
ABCL
|
$338M |
| 3 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$153M |
| 4 |
UnitedHealth
UNH
|
$137M |
| 5 |
Pfizer
PFE
|
$133M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$315M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$67.6M |
| 3 |
Ascendis Pharma
ASND
|
$66.4M |
| 4 |
Exelixis
EXEL
|
$58.8M |
| 5 |
Eledon Pharmaceuticals
ELDN
|
$46.7M |
Sector Composition
| 1 | Healthcare | 98.28% |
| 2 | Financials | 0.52% |
| 3 | Technology | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Keros Therapeutics
KROS
$618M
| $118M | 1.04% | 1,679,417 | – | – |
|
27
Repare Therapeutics
RPTX
$71.7M
| $118M | 1.03% | 3,426,325 | – | – |
|
28
Humana
HUM
$36.5B
| $117M | 1.03% | 286,100 +5,800 | +2% | +$2.38M |
|
29
Theravance Biopharma
TBPH
$699M
| $111M | 0.97% | 6,219,110 | – | – |
|
|
NSTG
30
DELISTED
NanoString Technologies, Inc.
NSTG
| $109M | 0.95% | 1,626,900 +443,800 | +38% | +$29.7M |
|
31
DexCom
DXCM
$29.5B
| $103M | 0.9% | 279,100 +52,700 | +23% | +$19.5M |
|
32
Elevance Health
ELV
$71.8B
| $99.7M | 0.87% | +310,500 | New | +$99.7M |
|
33
Oric Pharmaceuticals
ORIC
$994M
| $98.9M | 0.87% | 2,921,967 | – | – |
|
|
BNR
34
Burning Rock Biotech
BNR
$93.6M
| $96.1M | 0.84% | 4,161,675 -584,400 | -12% | -$13.5M |
|
35
Agios Pharmaceuticals
AGIO
$2.19B
| $95.6M | 0.84% | 2,207,321 | – | – |
|
36
Adicet Bio
ACET
$59.9M
| $94.3M | 0.82% | 6,708,507 | – | – |
|
37
Edwards Lifesciences
EW
$47.8B
| $93.6M | 0.82% | 1,025,800 +319,300 | +45% | +$29.1M |
|
38
AbbVie
ABBV
$372B
| $92.4M | 0.81% | 862,300 +398,300 | +86% | +$42.7M |
|
39
Intuitive Surgical
ISRG
$170B
| $92.3M | 0.81% | 112,800 | – | – |
|
40
Sarepta Therapeutics
SRPT
$1.78B
| $91.9M | 0.8% | 539,049 | – | – |
|
41
89bio
ETNB
$1.34B
| $90.9M | 0.8% | 3,729,442 | – | – |
|
42
Xtant Medical Holdings
XTNT
$83.3M
| $87.1M | 0.76% | 72,803,072 +63,554,394 | +687% | +$76M |
|
|
SVA
43
DELISTED
Sinovac Biotech, Ltd
SVA
| $72M | 0.63% | 2,839,500 | – | – |
|
44
Progyny
PGNY
$2.04B
| $71M | 0.62% | 1,675,500 | – | – |
|
45
Guardant Health
GH
$8.41B
| $69.4M | 0.61% | 538,200 +383,900 | +249% | +$49.5M |
|
46
CRISPR Therapeutics
CRSP
$4.71B
| $69.2M | 0.61% | 451,800 -178,204 | -28% | -$27.3M |
|
47
AtriCure
ATRC
$1.84B
| $68.4M | 0.6% | 1,228,189 | – | – |
|
|
TCDA
48
DELISTED
Tricida, Inc. Common Stock
TCDA
| $67.8M | 0.59% | 9,614,280 | – | – |
|
49
Aurinia Pharmaceuticals
AUPH
$1.58B
| $65.7M | 0.58% | 4,754,000 | – | – |
|
|
LOGC
50
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $64.6M | 0.57% | 8,466,783 +2,000,000 | +31% | +$15.3M |
|